相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sclerostin as Regulatory Molecule in Vascular Media Calcification and the Bone-Vascular Axis
Annelies De Mare et al.
TOXINS (2019)
The skeletal cell-derived molecule sclerostin drives bone marrow adipogenesis
Heather Fairfield et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know
Pierre Delanaye et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Validation of a novel, rapid, high precision sclerostin assay not confounded by sclerostin fragments
Matthew T. Drake et al.
BONE (2018)
Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes
Soohyun P. Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD
Geert J. Behets et al.
PLOS ONE (2017)
Interactions of sclerostin with FGF23, soluble klotho and vitamin D in renal transplantation
Lida Tartaglione et al.
PLOS ONE (2017)
Sclerostin Immunoreactivity Increases in Cortical Bone Osteocytes and Decreases in Articular Cartilage Chondrocytes in Aging Mice
Michelle L. Thompson et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2016)
How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits
Isabelle Piec et al.
CALCIFIED TISSUE INTERNATIONAL (2016)
Sclerostin Enhances Adipocyte Differentiation in 3T3-L1 Cells
Mayumi Ukita et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Sclerostin levels in CKD patients: an important, but not definitive, step on the way to clinical use
Pierre Delanaye et al.
KIDNEY INTERNATIONAL (2015)
Sclerostin and DKK1: new players in renal bone and vascular disease
Pieter Evenepoel et al.
KIDNEY INTERNATIONAL (2015)
Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism
Geert J. Behets et al.
KIDNEY INTERNATIONAL (2015)
Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification
Abdul Rashid Qureshi et al.
KIDNEY INTERNATIONAL (2015)
High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study
Christiane Drechsler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Inter-method variability in bone alkaline phosphatase measurement: Clinical impact on the management of dialysis patients
Etienne Cavalier et al.
CLINICAL BIOCHEMISTRY (2014)
Renal Elimination of Sclerostin Increases With Declining Kidney Function
Daniel Cejka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Clinical and Biological Determinants of Sclerostin Plasma Concentration in Hemodialysis Patients
Pierre Delanaye et al.
NEPHRON CLINICAL PRACTICE (2014)
Prelamin A Accelerates Vascular Calcification Via Activation of the DNA Damage Response and Senescence-Associated Secretory Phenotype in Vascular Smooth Muscle Cells
Yiwen Liu et al.
CIRCULATION RESEARCH (2013)
Standardized Nomenclature, Symbols, and Units for Bone Histomorphometry: A 2012 Update of the Report of the ASBMR Histomorphometry Nomenclature Committee
David W. Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Association of Circulating Sclerostin With Bone Mineral Mass, Microstructure, and Turnover Biochemical Markers in Healthy Elderly Men and Women
Claire Durosier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?
Liesbeth Viaene et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium
Zachary C. Ryan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Sclerostin and Its Association with Physical Activity, Age, Gender, Body Composition, and Bone Mineral Content in Healthy Adults
Karin Amrein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
SCLEROSTIN AS POTENTIAL NOVEL BIOMARKER FOR AORTIC VALVE CALCIFICATION
Ralf Koos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study
M. -S. M. Ardawi et al.
OSTEOPOROSIS INTERNATIONAL (2012)
The Role of Sclerostin in the Pathophysiology of Sclerosing Bone Dysplasias
A. H. van Lierop et al.
CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM (2012)
Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men
Ulrike I. Moedder et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Acute Decline in Serum Sclerostin in Response to PTH Infusion in Healthy Men
Elaine W. Yu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
The Appearance and Modulation of Osteocyte Marker Expression during Calcification of Vascular Smooth Muscle Cells
Dongxing Zhu et al.
PLOS ONE (2011)
Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
Asiri R. Wijenayaka et al.
PLOS ONE (2011)
Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls
A. H. van Lierop et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Effects of Parathyroid Hormone Treatment on Circulating Sclerostin Levels in Postmenopausal Women
Matthew T. Drake et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal Women
Faryal S. Mirza et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Osteoprotegerin as a Predictor of Coronary Artery Disease and Cardiovascular Mortality and Morbidity
Shreenidhi M. Venuraju et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin
Alexander G. Robling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling
XF Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification
KL Tyson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
ME Brunkow et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
W Balemans et al.
HUMAN MOLECULAR GENETICS (2001)
分享论文
